Bio-Rad Life Sciences Logs 1 Percent Q1 Growth on Double-digit Sales of Digital PCR Products | GenomeWeb

Bio-Rad executives said this week that first-quarter sales of the firm's digital PCR platform and related products increased year over year, helping to drive approximately 1 percent year-over-year and 2.5 percent sequential growth in the company's Life Science segment.

The uptick in Life Science sales buoyed Bio-Rad's overall revenues, which crept up 3 percent year over year but fell short of consensus analyst estimates on the top and bottom lines due to what the company called "softness" in research markets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."